GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Kymera Therapeutics rises 7.21% in Wednesday's session

Published by Global Banking & Finance Review

Posted on November 4, 2026

1 min read
Add as preferred source on Google
KYMR 136.25 +7.21% last traded price, 4 Nov 2026
Previous close
127.09
Market cap
—

The figures in this article were checked against this snapshot before publication.

Kymera Therapeutics shares last traded at 136.25 USD, 7.21% higher than their previous close of 127.09 USD in the United States health care market on 4 November 2026.

Last traded price136.25 USD
Previous close127.09 USD
Change from the previous close+7.21%

Prices of Kymera Therapeutics (KYMR), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 4 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 3 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where the previous session's trading was worth at least US$5 million. How we compile these reports.

Kymera Therapeutics — daily KYMR Delayed

Related Articles

More from Markets

Explore more articles in the Markets category